Hypertensive retinopathy: Comparing the Keith-Wagener-Barker to a simplified classification

Journal of Hypertension

Volumn 31, Issue 5, 2013, Pages 960-965

  Downie, Laura E ^a   Hodgson, Lauren A B ^a   Dsylva, Carly ^a   McIntosh, Rachel L ^a   Rogers, Sophie L ^a   Connell, Paul ^b   Wong, Tien Y ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

arteriovenous nicking; cardiovascular disease; cotton wool patch; hemorrhage; hypertension; hypertensive retinopathy; Keith?Wagener?Barker; microvasculature; retina

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIGITAL RETINAL IMAGE; DISEASE CLASSIFICATION; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION RETINOPATHY; IMAGING; INTERMETHOD COMPARISON; KEITH WAGENER BARKER SYSTEM; MAJOR CLINICAL STUDY; MITCHELL WONG SYSTEM; OPHTHALMOLOGIST; OPTOMETRIST; PRIORITY JOURNAL;

EID: 84876293461     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835efea3     Document Type: Article

References (47)

1. Liebreich R. Ophthalmoskopischer Befund bei Morbus Brightii [Ophthalmoscopic findings in Bright's disease]. Albrecht von Graefes Arch Ophthalmol 1859; 5:265-268.
2. Walsh JB. Hypertensive retinopathy: description, classification and prognosis. Ophthalmology 1982; 89:1127-1131.
3. -1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17:151-183.
4. Wong TY. Fred Hollows Lecture: Hypertensive retinopathy-a journey from fundoscopy to digital imaging. Clin Exp Ophthalmol 2006; 34:397-400.
5. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1751-1762.
6. Wong TY, Mitchell P. The eye in hypertension. Lancet 2007; 3;369:425-435.
7. Dimmitt SB, West JN, Eames SM, Gibson JM, Gosling P, Littler WA. Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet 1989; 1:1103-1106.
8. Kagan A, Aureli E, Dobree J. A note on signs in the fundus oculi and arterial hypertension: conventional assessment and significance. Bull WHO 1966; 34:955-960.
9. Scheie HG. Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. AMA Arch Ophthalmol 1953; 49:1170-1238.
10. Breslin DJ, Gifford RW Jr, Fairbarin FJ II, Kearns TP. Prognostic importance of ophthalmoscopic findings in essential hypertension. JAMA 1966; 195:335-338.
11. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939; 197:332-343.
12. Gunn RM. Ophthalmoscopic evidence of (1) arterial changes associated with chronic renal diseases and (2) of increased arterial tension. Trans Ophthalmol Soc UK 1892; 12:124-125.
13. Dodson PM, Lip GY, Eames SM, Gibson JM, Beevers DG. Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system. J Hum Hypertens 1996; 10:93-98.
14. Schubert HD. Ocular manifestations of systemic hypertension. Curr Opin Ophthalmol 1998; 9:69-72.
15. Wong TY, Klein R, Klein BEK, Tielsch JM, Hubbard LD, Nieto FJ. Retinal microvascular abnormalities, and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 2001; 46: 59-80.
16. Chatterjee S, Chattopadhyay S, Hope-Ross M, Lip PL. Hypertension and the eye: changing perspectives. J Hum Hypertens 2002; 16:667-675.
17. Cuspidi C, Salerno M, Salerno DE, Meani S, Esposito A, Catini E, et al. High prevalence of retinal vascular changes in never-treated essential hypertensives: an inter-and intra-observer reproduci-bility study with nonmydriatic retinography. Blood Press 2004; 13: 25-30.
18. Cuspidi C, Negri F, Giudici V, Sala C. Retinal changes and cardiac remodelling in systemic hypertension. Ther Adv Cardiovasc Dis 2009; 3:205-214.
19. Fuchs FD, Maestri MK, Bredemeier M, Cardozo SE, Moreira FC, Wainstein MV, et al. Study of the usefulness of optic fundii examination of patients with hypertension in a clinical setting. J Hum Hypertens 1995; 9:547-551.
20. Cuspidi C, Meani S, Salerno N, Fusi V, Severgnini B, Valerio C, et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22:2095-2102.
21. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004; 351:2310-2317.
22. Altman DG. Practical statistics for medical research. London, England: Chapman and Hall; 1991, p. 404.
23. Yanoff M, Duker JS. Ophthalmology. 3rd ed. Mosby Elsevier; 2009.
24. Berg D, Worzala K. Atlas of adult physical diagnosis. Philadelphia: Lippincott Williams & Wilkins; 2006.
25. Lanzer P, Topol EJ. Pan Vascular medicine: integrated clinical management. Berlin, Heidelberg: Springer; 2002.
26. McFarlane SI, Bakris GL. Diabetes and hypertension: evaluation and management. New York: Springer; 2012.
27. Sairenchi T, Iso H, Yamagishi K, Irie F, Okubp Y, Gunji J, et al. Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension. The Ibaraki Prefectural Health Study. Circulation 2011; 124:2502-2511.
28. Abi T, Tsuda A, Yata S, Matsuto T, Okada M. Hypertension is a major risk factor for future atherosclerotic changes in the Japanese population. Ann Clin Biochem 2010; 47 (Pt 2):118-124.
29. Apikoglu M, Bulucu F, Demirbas S, Ay SA, Karaman M, Altun B, et al. The relationship between microalbuminuria, left ventrical hypertrophy, retinopathy and sex hormone status in newly diagnosed hypertensive women. Clin Exp Hypertens 2012. [Epub ahead of print]
30. Bulur S, Önder HI, Aslantas Y, Ekinozu I, Kilic AÇ, Yalcin S, et al. Relation between indices of end-organ damage and mean platelet volume in hypertensive patients. Blood Coagul Fibrinolysis 2012; 23:367-369.
31. Bakalli A, Koçinaj D, Bakalli A, Krasnigi A. Relationship of hypertensive retinopathy to thoracic aortic atherosclerosis in patients with severe arterial hypertension. Clin Exp Hypertens 2011; 33:89-94.
32. Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN, Hubbard LD, et al. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 2006; 37:82-86.
33. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, et al. Retinal microvascular abnormalities and incident strokes: the Atherosclerosis Risk in Communities Study. Lancet 2001; 358:1134-1140.
34. Yatsuya H, Folsom AR, Wong TY, Klein R, Klein BE, Sharrett AR, ARIC Study Investigators. Retinal microvascular abnormalities and risk of lacunar stroke: The Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010; 41:1439-1455.
35. De Silva DA, Manzano JJ, Liu EY, Woon FP, Wong WX, Chang HM, et al., Multi-Centre Retinal Stroke Study Group. Retinal microvascular changes and subsequent vascular events after ischemic stroke. Neurology 2011; 77:896-903.
36. Duncan BB, Wong TY, Tyroler HA, Davis CE, Fuchs FD. Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol 2002; 86:1002-1006.
37. Tikellis G, Arnett DK, Skelton TN, Taylor HW, Klein R, Couper DJ, et al. Retinal arteriolar narrowing and left ventricular hypertrophy in African Americans. The Atherosclerosis Risk in Communities (ARIC) study. Am J Hypertens 2008; 21:352-359.
38. Wong TY, Coresh J, Klein R, Muntner P, Couper DJ, Sharrett AR, et al. Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study. J Am Soc Nephrol 2004; 15:2469-2476.
39. Wong TY, McIntosh R. Systemic associations of retinal microvascular signs: a review of recent population-based studies. Ophthal Physiol Opt 2005; 25:195-204.
40. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM, et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA 2002; 288:67-74.
41. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, et al. Cerebral white matter lesion, retinopathy and incident clinical stroke. JAMA 2002; 288:67-74.
42. Wong TY, Klein R, Sharrett AR, Marino EK, Sharrett AR, Siscovick DS, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 2002; 33:1487-1492.
43. Wong TY, Klein R, Nieto FJ, Klein BE, Sharrett AR, Meuer SM, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology 2003; 110:933-940.
44. Wang JJ, Baker ML, Hand PJ, Hankey GJ, Lindley RI, Rochtchina E, et al. Transient ischemic attack and acute ischemic stroke: associations with retinal microvascular signs. Stroke 2011; 42:404-408.
45. Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR. Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 2005; 65:1005-1009.
46. Cheung CY, Ikram MK, Sabanayagam C, Wong TY. Retinal micro-vasculature as a model to study the manifestations of hypertension. Hypertension 2012; 60:1094-1103.
47. Wong TY, Rosamond W, Chang PP, Couper DJ, Sharrett AR, Hubbard LD, et al. Retinopathy and risk of congestive heart failure. JAMA 2005; 293:63-69.